Zhilei Su

865 total citations
18 papers, 458 citations indexed

About

Zhilei Su is a scholar working on Cancer Research, Molecular Biology and Epidemiology. According to data from OpenAlex, Zhilei Su has authored 18 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Zhilei Su's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (5 papers). Zhilei Su is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (5 papers). Zhilei Su collaborates with scholars based in China, Hong Kong and Germany. Zhilei Su's co-authors include Xingming Jiang, Sheng Tai, Shounan Lu, Wen Fu, Zhifa Liu, Pengcheng Kang, Yunfu Cui, Yi Xu, Xiangyu Zhong and Chunlong Li and has published in prestigious journals such as Chemical Engineering Journal, Frontiers in Microbiology and Clinica Chimica Acta.

In The Last Decade

Zhilei Su

18 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhilei Su China 11 373 350 56 44 30 18 458
Shengning Zhang China 8 238 0.6× 293 0.8× 16 0.3× 30 0.7× 29 1.0× 25 404
Luhui Cai China 7 274 0.7× 529 1.5× 36 0.6× 26 0.6× 18 0.6× 8 593
Qianqing Wang China 10 224 0.6× 321 0.9× 74 1.3× 34 0.8× 22 0.7× 23 473
Esmat Abdi Iran 11 171 0.5× 195 0.6× 110 2.0× 26 0.6× 53 1.8× 22 332
Chengfeng Wang China 5 423 1.1× 422 1.2× 32 0.6× 78 1.8× 19 0.6× 9 539
Huaiming Sang China 8 260 0.7× 299 0.9× 92 1.6× 30 0.7× 72 2.4× 20 420
Lien Lippens Belgium 10 167 0.4× 291 0.8× 21 0.4× 10 0.2× 41 1.4× 14 400
Zining Long China 6 134 0.4× 216 0.6× 19 0.3× 19 0.4× 64 2.1× 8 297
Qiyao Zhang China 12 289 0.8× 395 1.1× 22 0.4× 24 0.5× 53 1.8× 28 486
Sahar Jahangiri Canada 10 243 0.7× 300 0.9× 32 0.6× 11 0.3× 40 1.3× 17 442

Countries citing papers authored by Zhilei Su

Since Specialization
Citations

This map shows the geographic impact of Zhilei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhilei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhilei Su more than expected).

Fields of papers citing papers by Zhilei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhilei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhilei Su. The network helps show where Zhilei Su may publish in the future.

Co-authorship network of co-authors of Zhilei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Zhilei Su. A scholar is included among the top collaborators of Zhilei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhilei Su. Zhilei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Wenjing, Feng Zhang, Rui Sun, et al.. (2022). Epidemiologic and clinical characteristics of human bocavirus infection in children hospitalized for acute respiratory tract infection in Qingdao, China. Frontiers in Microbiology. 13. 935688–935688. 16 indexed citations
2.
Tai, Sheng, et al.. (2022). One-half layer pancreaticojejunostomy with the rear wall of the pancreas reinforced: A valuable anastomosis technique. World Journal of Clinical Cases. 10(26). 9276–9284. 1 indexed citations
3.
Su, Zhilei, Guanying Ye, Suqin Liu, & Zhen He. (2022). A template-free I2-assisted pyrolysis strategy to synthesize coral-like nitrogen-doped carbon with a regulated hierarchical porous structure toward efficient oxygen reduction. Chemical Engineering Journal. 440. 135852–135852. 16 indexed citations
4.
Xia, Haoming, Ziyue Huang, Shuqiang Liu, et al.. (2021). Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 653846–653846. 3 indexed citations
5.
Huang, Ziyue, Haoming Xia, Shuqiang Liu, et al.. (2021). The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 714665–714665. 10 indexed citations
6.
Xia, Haoming, Ziyue Huang, Shuqiang Liu, et al.. (2021). LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors. Biomedicine & Pharmacotherapy. 141. 111889–111889. 5 indexed citations
7.
Xu, Yi, Ping Gao, Zhidong Wang, et al.. (2021). Circ‐LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR‐556‐5p and miR‐567 mediated YY1 activation. Journal of Cellular and Molecular Medicine. 25(7). 3226–3238. 21 indexed citations
9.
Su, Zhilei, et al.. (2020). Genome Sequence of a Human Coxsackievirus A6 Strain Isolated from a Severe Hand, Foot, and Mouth Disease Case in Qingdao, China, in 2017. Microbiology Resource Announcements. 9(17). 1 indexed citations
10.
Lu, Shounan, et al.. (2019). Altered expression of long non-coding RNA GAS5 in digestive tumors. Bioscience Reports. 39(1). 28 indexed citations
11.
Xu, Yi, Yue Yao, Yueping Liu, et al.. (2019). Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma. Aging. 11(7). 1907–1917. 53 indexed citations
12.
Shi, Xiaoyan, Yanhui Zhang, Zhilei Su, et al.. (2018). Genetic characteristics of CV-A12 VP1 region and clinical manifestations of CV-A12-associated severe hand, foot and mouth disease in Qingdao. Zhonghua weishengwuxue he mianyixue zazhi. 38(9). 658–664. 1 indexed citations
13.
Wu, Dehai, Hao Liang, Shounan Lu, et al.. (2018). miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism. Cellular Physiology and Biochemistry. 50(3). 924–935. 44 indexed citations
14.
Su, Zhilei, Shounan Lu, Wen Fu, et al.. (2018). LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clinica Chimica Acta. 485. 229–233. 195 indexed citations
15.
Li, Zhenglong, Xingming Jiang, Zhilei Su, et al.. (2018). Current insight into a cancer-implicated long noncoding RNA ZFAS1 and correlative functional mechanisms involved. Pathology - Research and Practice. 214(10). 1517–1523. 11 indexed citations
16.
Su, Zhilei, et al.. (2018). Diagnosis and management of primary hepatic pregnancy: literature review of 31 cases. Archives of Gynecology and Obstetrics. 298(2). 235–242. 6 indexed citations
17.
Lu, Shounan, et al.. (2018). The role of the long non‐coding RNA HOXA11‐AS in promoting proliferation and metastasis of malignant tumors. Cell Biology International. 42(12). 1596–1601. 16 indexed citations
18.
Wu, Dehai, Liang Hao, Hao Wang, et al.. (2018). Hepatitis B virus‑X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma. Oncology Letters. 16(4). 4418–4426. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026